The National Average for Gross Revenue at ECP Locations Decreased for the Week of May 9-15, Jobson’s Latest Practice Performance Tracker Shows

NEW YORK—The national average for gross revenue at ECP locations decreased last week, May 9-15, at a rate of -2 index points. That places gross revenue at a level 7 index points above where it was at this point in time (week 20) when compared with last year and 12 points above 2019. Gross revenue during Week 20 of 2020 was 42 index points below Week 20 of this year at a level of 68 index points, as it continued to gradually emerge from the pandemic-related low of 14 index points it had reached during Week 15 of 2020, according to Jobson’s most recent Practice Performance Tracker.

Warby Parker Reports 10 Percent Increase in Q1 Sales as ‘Active’ Customer Count Climbs 18 Percent, But Net Loss Also Widens

NEW YORK—Against a backdrop of disruption due to the Omicron variant that was first felt in the last weeks of December and continuing through the first quarter, Warby Parker Inc. (NYSE: WRBY) on Monday reported that its Q1 revenue rose 10.3 percent to $153.2 million as both active customer count and average revenue per customer increased also in the quarter ended March 31. However, the retailer's net loss totaled $34.1 million in the quarter, primarily as a result of an increase in SG&A (selling, general and administrative) expenses, according to its announcement.

Gryphon Investors Enters Vision Care With Investment in Vision Innovation Partners, Leading Eyecare Group in Mid-Atlantic Region

SAN FRANCISCO—Gryphon Investors (Gryphon), a leading middle-market private equity firm, has partnered with Vision Innovation Partners (VIP), a leading provider of eyecare services in the mid-Atlantic region. Financial terms of the transaction—which marks the investor group’s first move in the eyecare sector—were not disclosed. New York-based Centre Partners was an initial investor in VIP. According to the Centre Partners website, the firm no longer holds an ownership position following the Gryphon transaction.

Ciao, Mido—See You Soon

NEW YORK—After two years without a show, Mido 2022 kicked off in Milan on April 30 through May 2. The trade show was a celebration in more than one way: a reunion for so many, a marking of Mido’s 50th anniversary and a moment to welcome a new era with new energy. About 22,000 visitors from all around the world packed into the Fiera Milano Rho conference center for the event, coming together to network, collaborate and take stock of new technology and products. 

Prevent Blindness Declares Third Annual Inherited Retinal Disease (IRD) Genetic Testing Week as May 16-22

CHICAGO—Prevent Blindness has declared May 16-22, 2022 as the third annual “Inherited Retinal Disease (IRD) Genetic Testing Week.” Educational materials, such as a fact sheet, social media graphics, and a dedicated webpage, preventblindness.org/inherited-retinal-diseases/ are available. New this year to IRD Genetic Testing Week are two informational videos. Alina V. Dumitrescu, MD, clinical associate professor of ophthalmology and visual sciences, pediatric ophthalmology and strabismus, inherited eye disease at the University of Iowa hospitals and clinics, is featured in a new “IRD and Genetic Testing” episode in the Focus on Eye Health Expert Series.